Abstract:Introduction Recently, several genome-wide association studies (GWAS) have identified novel single nucleotide polymorphisms (SNPs) associated with breast cancer risk. However, most of the studies were conducted among Caucasians and only one from Chinese. Methods In the current study, we first tested whether 15 SNPs identified by previous GWAS were also breast cancer marker SNPs in this Chinese population. Then, we grouped the marker SNPs, and modeled them with clinical risk factors, to see the usage of these factors in breast cancer risk assessment. Two methods (risk factors counting and odds ratio (OR) weighted risk scoring) were used to evaluate the cumulative effects of the five significant SNPs and two clinical risk factors (age at menarche and age at first live birth). Results Five SNPs located at 2q35, 3p24, 6q22, 6q25 and 10q26 were consistently associated with breast cancer risk in both testing set (878 cases and 900 controls) and validation set (914 cases and 967 controls) samples. Overall, all of the five SNPs contributed to breast cancer susceptibility in a dominant genetic model (2q35, rs13387042: adjusted OR = 1.26, P = 0.006; 3q24.1, rs2307032: adjusted OR = 1.24, P = 0.005; 6q22.33, rs2180341: adjusted OR = 1.22, P = 0.006; 6q25.1, rs2046210: adjusted OR = 1.51, P = 2.40 × 10 -8 ; 10q26.13, rs2981582: adjusted OR = 1.31, P = 1.96 × 10 -4 ). Risk score analyses (area under the curve (AUC): 0.649, 95% confidence interval (CI): 0.631 to 0.667; sensitivity = 62.60%, specificity = 57.05%) presented better discrimination than that by risk factors counting (AUC: 0.637, 95% CI: 0.619 to 0.655; sensitivity = 62.16%, specificity = 60.03%) ( P < 0.0001). Absolute risk was then calculated by the modified Gail model and an AUC of 0.658 (95% CI = 0.640 to 0.676) (sensitivity = 61.98%, specificity = 60.26%) was obtained for the combination of five marker SNPs, age at menarche and age at first live birth. Conclusions This study shows that five GWAS identified variants were also consistently validated in this Chinese population and combining these genetic variants with other risk factors can improve the risk predictive ability of breast cancer. However, more breast cancer associated risk variants should be incorporated to optimize the risk assessment.

Evaluation of Functional Genetic Variants at 6q25.1 and Risk of Breast Cancer in a Chinese Population

Genetic Variants of 6q25 and Breast Cancer Susceptibility: a Two-Stage Fine Mapping Study in a Chinese Population

Evaluation of Potential Regulatory Function of Breast Cancer Risk Locus at 6Q25.1.

SNP Rs17079281 Decreases Lung Cancer Risk Through Creating an YY1-Binding Site to Suppress DCBLD1 Expression

Genome-wide Association Study Identifies a New Breast Cancer Susceptibility Locus at 6Q25.1.

Association of Five Single Nucleotide Polymorphisms at 6q25.1 with Breast Cancer Risk in Northwestern China.

The Association of CASC16 Variants with Breast Cancer Risk in a Northwest Chinese Female Population

Identification of A Functional Genetic Variant at 16q12.1 for Breast Cancer Risk: Results from the Asia Breast Cancer Consortium

Quantitative Assessment of the Association Between Rs2046210 at 6q25.1 and Breast Cancer Risk.

Evaluation of Breast Cancer Susceptibility Loci in Chinese Women.

Breast Cancer Risk-Associated Variants at 6q25.1 Influence Risk of Hepatocellular Carcinoma in a Chinese Population.

Genetic Variants at Chromosome 9p21, 10p15 and 10q22 and Breast Cancer Susceptibility in a Chinese Population

Association Between a Novel Polymorphism (rs2046210) of the 6q25.1 Locus and Breast Cancer Risk

Identification of Potential Functional Variants and Genes at 18q21.1 Associated with the Carcinogenesis of Colorectal Cancer.

Breast Cancer Risk Assessment with Five Independent Genetic Variants and Two Risk Factors in Chinese Women

Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs

Genome-Wide Association Study Identifies Breast Cancer Risk Variant at 10q21.2: Results from the Asia Breast Cancer Consortium

Genetic Variants at 14q24.1 and Breast Cancer Susceptibility: a Fine-Mapping Study in Chinese Women

Association of Multiple Genetic Variants with Breast Cancer Susceptibility in the Han Chinese Population

luation of Breast Cancer Susceptibility Loci in B & P nese Women

Genetic Variants at 1p11.2 and Breast Cancer Risk: A Two-Stage Study in Chinese Women